Full Job Description
This position will carry out oligonucleotide analytical development to support our Oligonucleotide Transport Vehicle (OTV) platform. This is an exciting and unique opportunity to contribute to several programs and position us for the future as our groundbreaking OTV therapeutics enter the clinical phase.
Key Accountabilities/ Core Job Responsibilities:
• Design, execute, and interpret stability-indicating chromatographic methods for ASOs/siRNA.
• Develop and apply complementary characterization techniques for ASOs/siRNA, including UV–Vis spectroscopy, mass spectrometry, NMR, Karl Fischer titration, differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), and circular dichroism (CD).
• Analyze and interpret results, leveraging knowledge of oligonucleotide synthesis and purification processes to understand impurity profiles.
• Transfer analytical methods and manage activities at partner CDMOs, as needed (travel may be required).
• Author and/or review analytical data, specifications, Certificates of Analysis, and method validation protocols and reports.
• Collaborate with discovery scientists, process chemists, quality, and project teams to advance our portfolio and analytical strategies and ensure timely flow of information.
• Experience with modern artificial intelligence or machine-learning approaches to support chemistry workflows is a plus.
• Perform other responsibilities as needed.
Qualifications/Skills:
• M.Sc./B.Sc. with 5+ years of relevant experience, with a record of scientific leadership and innovation as demonstrated by publications and/or patents
• Deep understanding of and demonstrated excellence in the analysis of oligonucleotides and their starting materials.
• Expertise in mass spectrometry is expected
• Knowledge of phase-appropriate QC/analytics relevant to oligonucleotide analysis
• Strong written and verbal communication skills
This compensation and benefits information is based on Denali’s good faith estimate as of the date of publication and may be modified in the future.